Rating History for Relmada Therapeutics Inc (RLMD) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/24/2026 | Kelsey Goodwin | New Coverage | Overweight (N/A) |
12.00 (N/A) |
6.07 (6.77) |
11.53% | Details |
